P2y2 receptor activation decreases blood pressure and increases renal Na+ excretion

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 301, Issue 2, 2011, Pages

  Rieg, Timo ^a,b   Gerasimova, Maria ^b   Boyer, José L ^c   Insel, Paul A ^a,d   Vallon, Volker ^a,b,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Inspire Pharmaceuticals   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INS 45973; NITRIC OXIDE; PURINERGIC P2Y RECEPTOR AGONIST; PURINERGIC P2Y2 RECEPTOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE; INOSINE; INS45973; PURINERGIC RECEPTOR STIMULATING AGENT; URIDINE TRIPHOSPHATE;

ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; GENE ACTIVATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; POTASSIUM EXCRETION; PRIORITY JOURNAL; SMOOTH MUSCLE; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM URINE LEVEL; URINALYSIS; URINARY EXCRETION; VASOCONSTRICTION; VASODILATATION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; INOSINE; KIDNEY; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; PURINERGIC AGONISTS; RECEPTORS, PURINERGIC P2Y2; URIDINE TRIPHOSPHATE;

EID: 79961054840     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00148.2011     Document Type: Article

References (60)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341, 2006.
2. Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F, Boeynams JM, Bult H, Robaye B. Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74: 777-784, 2008.
3. Boarder MR, Hourani SMO. The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 19: 99-107, 1998.
4. 2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 866-873, 2000.
5. Dietrich HH, Kajita Y, Dacey RG. Local and conducted vasomotor responses in isolated rat cerebral arterioles. Am J Physiol Heart Circ Physiol 271: H1109-H1116, 1996.
6. 2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells. Br J Pharmacol 160: 1953-1962, 2010.
7. Guns PJ, Korda A, Crauwels HM, Van Assche T, Robaye B, Boeynaems JM, Bult H. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol 146: 288-295, 2005.
8. 2-deficient mice. Br J Pharmacol 147: 569-574, 2006.
9. Harhun MI, Povstyan OV, Gordienko DV. Purinoreceptor-mediated current in myocytes from renal resistance arteries. Br J Pharmacol 160: 987-997, 2010.
10. 4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol 124: 703-710, 1998.
11. Homolya L, Watt WC, Lazarowski ER, Koller BH, Boucher RC. Nucleotide-regulated calcium signaling in lung fibroblasts and epithelialcells from normal and P2Y2 receptor (-/-) mice. J Biol Chem 274: 26454-26460, 1999.
12. Horiuchi T, Dietrich HH, Tsugane S, Dacey RG. Analysis of purineand pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol Heart Circ Physiol 280: H767-H776, 2001.
13. Hrafnkelsdottir T, Erlinge D, Jern S. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thromb Haemost 85: 875-881, 2001.
14. Inscho EW. ATP, P2 receptors and the renal microcirculation. Purinergic Signal 5: 447-460, 2009.
15. Janigro D, Nguyen TS, Meno J, West GA, Winn HR. Endotheliumdependent regulation of cerebrovascular tone by extracellular and intracellular ATP. Am J Physiol Heart Circ Physiol 273: H878-H885, 1997.
16. Jankowski M, Angielski S, Szczepanska-Konkel M. Dissociation between the effects of P1, P4-diadenosine tetraphosphate (Ap4A) on renal haemodynamics and tubular function in anaesthetized rats. J Physiol Pharmacol 59: 129-137, 2008.
17. Jankowski V, Tolle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, Schluter H, Paul M, Zidek W, Jankowski J. Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 11: 223-227, 2005.
18. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orleans-Juste P, Marceau F, Thorin E, Sevigny J. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 85: 204-213, 2010.
19. Kennedy C, Burnstock G. ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery. Blood Vessels 22: 145-155, 1985.
20. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J 336: 513-523, 1998.
21. + absorption in isolated perfused mouse CCD. J Am Soc Nephrol 13: 10-18, 2002.
22. Ma X, Abboud FM, Chapleau MW. Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol 283: R1033-R1040, 2002.
23. Madeddu P, Varoni MV, Palomba D, Emanueli C, Demontis MP, Glorioso N, Dessi-Fulgheri P, Sarzani R, Anania V. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96: 3570-3578, 1997.
24. Malmsjo M, Chu ZM, Croft K, Erlinge D, Edvinsson L, Beilin LJ. P2Y receptor-induced EDHF vasodilatation is of primary importance for the regulation of perfusion pressure in the peripheral circulation of the rat. Acta Physiol Scand 174: 301-309, 2002.
25. Malmsjo M, Hou M, Harden TK, Pendergast W, Pantev E, Edvinsson L, Erlinge D. Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. J Pharmacol Exp Ther 293: 755-760, 2000.
26. 6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3: 4, 2003.
27. 2+ regulation after ischemia/reperfusion produces potentiated endothelium-derived hyperpolarizing factormediated dilations. Stroke 33: 2285-2291, 2002.
28. McMillan MR, Burnstock G, Haworth SG. Vasoconstriction of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets. Br J Pharmacol 128: 549-555, 1999.
29. 2 receptor agonists stimulate vaginal moisture in ovariectomized rabbits. Fertil Steril 79: 393-398, 2003.
30. Mizumori M, Ham M, Guth PH, Engel E, Kaunitz JD, Akiba Y. Intestinal alkaline phosphatase regulates protective surface microclimate pH in rat duodenum. J Physiol 587: 3651-3663, 2009.
31. 2 receptor tone. J Biol Chem 283: 36599-36607, 2008.
32. 2- receptor tone. FASEB J 24: 2056-2065, 2010.
33. Praetorius HA, Leipziger J. Intrarenal purinergic signaling in the control of renal tubular transport. Annu Rev Physiol 72: 377-393, 2010.
34. Ralevic V, Burnstock G. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res 69: 1583-1590, 1991.
35. Ralevic V, Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation 84: 1-14, 1991.
36. Ralevic V, Burnstock G. Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed. Br J Pharmacol 118: 428-434, 1996.
37. Ralevic V, Burnstock G. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed. Br J Pharmacol 117: 1797-1802, 1996.
38. Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16: 133-140, 2003.
39. Rayment SJ, Latif ML, Ralevic V, Alexander SPH. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries. Br J Pharmacol 150: 604-612, 2007.
40. Rhaleb NE, Peng H, Alfie ME, Shesely EG, Carretero OA. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role? Hypertension 33: 329-334, 1999.
41. + and water reabsorption. FASEB J 21: 3717-3726, 2007.
42. Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Arch Pharmacol 370: 320-323, 2004.
43. Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 313: 403-409, 2005.
44. Rieg T, Vallon V. ATP and adenosine in the local regulation of water transport and homeostasis by the kidney. Am J Physiol Regul Integr Comp Physiol 296: R419-R427, 2009.
45. Rosenblum WI, Nelson GH. Tone regulates opposing endotheliumdependent and -independent forces: resistance brain vessels in vivo. Am J Physiol Heart Circ Physiol 259: H243-H247, 1990.
46. Rosenblum WI, Nelson GH, Weinbrecht P. Histamine elicits competing endothelium-dependent constriction and endothelium-independent dilation in vivo in mouse cerebral arterioles. Stroke 21: 305-309, 1990.
47. Rubino A, Ziabary L, Burnstock G. Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries. Eur J Pharmacol 370: 139-143, 1999.
48. Ryan MJ, Didion SP, Davis DR, Faraci FM, Sigmund CD. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler Thromb Vasc Biol 22: 42-48, 2002.
49. Satterwhite CM, Farrelly AM, Bradley ME. Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol Heart Circ Physiol 276: H1091-H1097, 1999.
50. Shah MK, Kadowitz PJ. Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse. J Cardiovasc Pharmacol 39: 142-149, 2002.
51. Shaver SR, Rideout JL, Pendergast W, Douglass JG, Brown EG, Boyer JL, Patel RI, Redick CC, Jones AC, Picher M, Yerxa BR. Structure-activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors. Purinergic Signal 1: 183-191, 2005.
52. Szczepanska-Konkel M, Langner G, Bednarczuk G, Stiepanow-Trzeciak A, Jankowski M, Angielski S. Renal haemodynamics and natriuretic responses to intravenous administration of diadenosine tetraphosphate (Ap4A) and nicotinamide adenine dinucleotide (NAD) in rat. J Physiol Pharmacol 54: 163-173, 2003.
53. Tölle M, Schuchardt M, Wiedon A, Huang T, Klöckel L, Jankowski J, Jankowski V, Zidek W, van der Giet M. Differential effects of uridine adenosine tetraphosphateon purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 161: 530-540, 2010.
54. Vallon V. P2 receptors in the regulation of renal transport mechanisms. Am J Physiol Renal Physiol 294: F10-F27, 2008.
55. Vollmayer P, Clair T, Goding JW, Sano K, Servos J, Zimmermann H. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/ phosphodiesterases. Eur J Biochem 270: 2971-2978, 2003.
56. von Kugelgen I, Haussinger D, Starke K. Evidence for a vasoconstriction- mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol 336: 556-560, 1987.
57. von Kugelgen I, Starke K. Evidence for two separate vasoconstrictionmediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn Schmiedebergs Arch Pharmacol 341: 538-546, 1990.
58. Wihlborg AK, Malmsjo M, Eyjolfsson A, Gustafsson R, Jacobson K, Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarizing factor. Br J Pharmacol 138: 1451-1458, 2003.
59. Wildman SS, Marks J, Turner CM, Yew-Booth L, Peppiatt-Wildman CM, King BF, Shirley DG, Wang W, Unwin RJ. Sodium-dependent regulation of renal amiloride-sensitive currents by apical P2 receptors. J Am Soc Nephrol 19: 731-742, 2008.
60. Wildman S, Kang E, King B. ENaC, renal sodium excretion and extracellular ATP. Purinergic Signal 5: 481-489, 2009.